Scope of the Study
Digital PCR (dPCR) counts individual molecules for absolute quantification by dividing a sample into many individual real-time PCR reactions. Digital PCR and real-time PCR market have high growth prospects owing to growing healthcare infrastructure and increasing demand from the developing economies. Further, emphasizing on the development of portable and compact PCR devices and technological advancement expected to drive the demand for digital PCR and real-time PCR market over the forecasted period.
The market study is being classified by Type (Instruments and Reagents), by Application (Clinical [Pathogen Testing, Blood Screening, Oncology Testing, Others], Research and Forensic and Others) and major geographies with country level break-up.
Thermo Fisher Scientific, Inc. (United States), F. Hoffman-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (United States), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (United States), BioMérieux S.A. (France), Fluidigm Corporation (United States), Danaher Corporation (United States), Abbott Laboratories (United States), Merck KGaA (Germany) and Becton Dickinson and Company (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Promega Corporation (United States), Eppendorf AG (Germany) and Analytik Jena AG (Germany).
Leading global players are focusing on strategic partnerships to improve their products. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product offerings. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Digital PCR and Real-time PCR market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Digital PCR and Real-time PCR market by Type, Application and Region.
On the basis of geography, the market of Digital PCR and Real-time PCR has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-user, the sub-segment i.e. Hospitals will boost the Digital PCR and Real-time PCR market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Solution, the sub-segment i.e. Software will boost the Digital PCR and Real-time PCR market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing Prevalence of Genetic Disorders
- Government Initiatives for Human Genome Project
- Emphasizing On Development of Portable and Compact PCR Devices
- Technological Advancement in the PCR Devices
- High Cost Associated With Digital PCR and Real-Time PCR
- Stringent Government Regulations Regarding PCR Devices
- Increasing Demand for Plant Derived To Genome-Based Drug Discovery
- Growing Healthcare Infrastructure in the Developing Economies
- Lack of Advanced Medical in Facilities in the Emerging Economies
“PCR/qPCR/dPCR Assay Design, assays that are used in regulated environments must be taken through analytical validation and documentation in accordance with ICH guidelines that are recommended for adoption by the regulatory bodies of the European Union, Japan and USA6 for registration of pharmaceuticals for human use.”
Key Target AudienceHospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Forensic Laboratories and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase